Lutetium Lu 177 XT117
Term · Oncology and biomedicine · MLC-T-ONC-014926
A radioconjugate composed of XT117, a fibroblast activation protein inhibitor (FAPi), conjugated to the beta-emitting radioisotope lutetium Lu 177 (177Lu), with potential antineoplastic activity against FAP-expressing cancer-associated fibroblasts (CAFs). Upon administration, lutetium Lu 177 XT117 targets and binds to FAP-expressing CAFs. Upon binding, FAP-expressing CAFs are destroyed by 177Lu through the specific delivery of beta particle radiation. FAP, a cell surface protein, is overexpressed on CAFs in the tumor microenvironment (TME) of various cancers.
| Identifier | MLC-T-ONC-014926 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | 177Lu-labeled XT117; [177Lu]Lu-XT117; Lu-177-XT117 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014926",
"term": "Lutetium Lu 177 XT117",
"field": "Oncology and biomedicine",
"definition": "A radioconjugate composed of XT117, a fibroblast activation protein inhibitor (FAPi), conjugated to the beta-emitting radioisotope lutetium Lu 177 (177Lu), with potential antineoplastic activity against FAP-expressing cancer-associated fibroblasts (CAFs). Upon administration, lutetium Lu 177 XT117 targets and binds to FAP-expressing CAFs. Upon binding, FAP-expressing CAFs are destroyed by 177Lu through the specific delivery of beta particle radiation. FAP, a cell surface protein, is overexpressed on CAFs in the tumor microenvironment (TME) of various cancers.",
"synonyms": [
"177Lu-labeled XT117",
"[177Lu]Lu-XT117",
"Lu-177-XT117"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/lutetium-lu-177-xt117/"
}
Record 10,408 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.